Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 2, 2018

Medicortex starts clinical trial of TBI detection kit

Biotechnology company Medicortex Finland has launched the Phase II clinical trial of ProbTBI diagnostic kit for Traumatic Brain Injury (TBI) detection following the enrolment of the first patient.

Biotechnology company Medicortex Finland has launched the Phase II clinical trial of ProbTBI diagnostic kit for Traumatic Brain Injury (TBI) detection following the enrolment of the first patient.

The company will carry out additional enrolments for the trial in the central hospitals of Turku and Pori in Finland during the next few months.

Medicortex CEO Dr Adrian Harel said: “ProbTBI is a highly innovative and advanced diagnostic kit for rapid detection of TBI, and now it is further developed in this second trial.”

The trial is expected to enrol up to 160 study subjects, a majority of which will be healthy control patients suffering from head injury or with bone fractures.

The patient population will be divided into three subgroups to receive the best study results.

“Medicortex plans to quickly advance its second clinical trial to confirm the promising findings of its previous proof-of-concept study.”

Under this study, Medicortex intends to determine the biomarker levels in the study groups.

Content from our partners
“Everything is custom”: Behind the scenes of medical wire solutions
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials

Medicortex medical director Dr Mårten Kvist said: “Medicortex plans to quickly advance its second clinical trial to confirm the promising findings of its previous proof-of-concept study.

“Such a diagnostic tool is truly awaited and it will considerably improve the possibilities to detect a traumatic brain injury in patients who are suffering from symptoms caused by a hit to the head.”

The progression of the study can be followed at the clinical trials database in which the trial is posted.

Medicortex Finland is engaged in the development of a diagnostic kit for rapid detection of concussion and mild TBI.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU